Consenso uruguayo de manejo del infarto agudo de ... - SciELO

192. Fiore MC, Smith SS, Jorenby DE, Baker TB. The effectiveness of
the nicotine patch for smoking cessation: a meta-analysis. JAMA 1994; 271:
1940-7.
193. Kimmel SE, Berlin JA, Miles C, Jaskowiak J, Carson JL, Strom
BL. Risk of acute first myocardial infarction and use of nicotine patches in a
general population. J Am Coll Cardiol 2001; 37: 1297-302.
194. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA,
Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on
Prevention, Detection, Evaluation, and Treatment of High Blood Pressure:
the JNC 7 report. JAMA 2003; 289: 2560-72.
195. Furberg CD, Psaty BM, Meyer JV. Nifedipine: Dose-related
increase in mortality in patients with coronary heart disease. Circulation
1995; 92: 1326-31.
196. Malmberg K, Ryden L, Efendic S, Herlitz J, Nicol P,
Waldenstrom A, et al. Randomized trial of insulin-glucose infusion
followed by subcutaneous insulin treatment in diabetic patients with acute
myocardial infarction (DIGAMI study): effects on mortality at 1 year. J Am
Coll Cardiol; 26: 57-65.
197. UKProspective Diabetes Study (UKPDS) Group. Intensive bloodglucose
control with sulphonylureas or insulin compared with conventional
treatment and risk of complications in patients with type 2 diabetes (UKPDS
33). Lancet 1998; 352: 837-53.
198. Expert Panel on Detection, Evaluation and Treatment of High
Blood Cholesterol in Adults (Adult Treatment Panel III). Third Report
of the National Cholesterol Education Program (NCEP). Final Report
National Institutes of Health. NIH Publication No. 02-5215, September
2002.
199. Grundy SM, Cleeman JI, Merz CN, Brewer HB Jr, Clark LT,
Hunninghake DB, et al. Implications of recent clinical trials for the
National Cholesterol Education Program Adult Treatment Panel III
guidelines. Circulation 2004; 110: 227-39.
200. The Scandinavian Simvastatin Survival Study (4S) group.
Randomised trial of cholesterol lowering in 4444 patients with coronary
heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet
1994; 344: 1383-9.
201. Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD,
Cole TG, et al. The effect of pravastatin on coronary events after
myocardial infarction in patients with average cholesterol levels:
Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;
335: 1001-9.
202. The Long-Term Intervention with Pravastatin in Ischaemic
Disease (LIPID) Study Group. Prevention of cardiovascular events and
death with pravastatin in patients with coronary heart disease and a broad
range of initial cholesterol levels. N Engl J Med 1998; 339: 1349-57.
203. Riegger G, Abletshauser C, Ludwig M, Schwandt P, Widimsky J,